SG Americas Securities LLC Grows Holdings in Bruker Corporation $BRKR

SG Americas Securities LLC grew its position in shares of Bruker Corporation (NASDAQ:BRKR) by 134.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 99,173 shares of the medical research company’s stock after purchasing an additional 56,880 shares during the period. SG Americas Securities LLC owned 0.07% of Bruker worth $4,672,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of BRKR. Allworth Financial LP lifted its stake in shares of Bruker by 40.6% during the third quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock valued at $29,000 after buying an additional 257 shares during the period. Spire Wealth Management grew its stake in Bruker by 85.3% in the 3rd quarter. Spire Wealth Management now owns 1,445 shares of the medical research company’s stock worth $47,000 after acquiring an additional 665 shares during the period. Jones Financial Companies Lllp grew its stake in Bruker by 79.7% in the 3rd quarter. Jones Financial Companies Lllp now owns 2,773 shares of the medical research company’s stock worth $86,000 after acquiring an additional 1,230 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Bruker by 51.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,770 shares of the medical research company’s stock valued at $114,000 after acquiring an additional 942 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its stake in shares of Bruker by 9,800.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 4,851 shares of the medical research company’s stock worth $158,000 after purchasing an additional 4,802 shares during the period. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Bruker

In other news, VP Mark Munch sold 7,000 shares of Bruker stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $55.00, for a total value of $385,000.00. Following the transaction, the vice president directly owned 128,443 shares of the company’s stock, valued at $7,064,365. The trade was a 5.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders sold 11,000 shares of company stock valued at $554,280. Insiders own 27.30% of the company’s stock.

Bruker Stock Down 0.1%

Shares of NASDAQ BRKR opened at $36.08 on Thursday. Bruker Corporation has a 52-week low of $28.53 and a 52-week high of $56.22. The firm has a fifty day moving average of $39.18 and a 200-day moving average of $41.31. The stock has a market capitalization of $5.49 billion, a PE ratio of -240.53, a P/E/G ratio of 2.16 and a beta of 1.20. The company has a quick ratio of 0.87, a current ratio of 1.73 and a debt-to-equity ratio of 0.75.

Bruker (NASDAQ:BRKR) last issued its earnings results on Thursday, February 12th. The medical research company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.06). Bruker had a positive return on equity of 13.56% and a negative net margin of 0.25%.The firm had revenue of $977.20 million during the quarter, compared to analysts’ expectations of $964.61 million. During the same period last year, the business posted $0.76 earnings per share. The company’s quarterly revenue was down .2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, analysts anticipate that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 7th. Stockholders of record on Monday, March 23rd will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, March 23rd. Bruker’s dividend payout ratio (DPR) is -133.33%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on BRKR. Citigroup decreased their price objective on Bruker from $53.00 to $40.00 and set a “neutral” rating on the stock in a report on Friday, February 13th. Bank of America increased their target price on Bruker from $43.00 to $60.00 and gave the stock a “buy” rating in a research report on Monday, December 15th. Weiss Ratings reissued a “sell (d+)” rating on shares of Bruker in a research note on Friday, March 27th. Wells Fargo & Company lifted their price target on Bruker from $48.00 to $55.00 and gave the company an “overweight” rating in a report on Monday, December 15th. Finally, UBS Group reaffirmed a “neutral” rating and set a $49.00 price objective on shares of Bruker in a research note on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Bruker currently has a consensus rating of “Hold” and a consensus target price of $49.77.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.